6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group - Büchner, T; Hiddemann, W; Berdel, WE; Wörmann, B; Schoch, C; Fonatsch, C; Löffler, H; Haferlach, T; Ludwig, WD; Maschmeyer, G; Staib, P; Aul, C; Gruneisen, A; Lengfelder, E; Frickhofen, N; Kern, W; Serve, HL; Mesters, RM; Sauerland, MC; Heinecke, A; German AML Cooperative Group. (J Clin Oncol, 2003)